NEW YORK (GenomeWeb News) - The University of Ottawa Heart Institute is using Affymetrix technology for whole-genome association studies of coronary artery disease, the company said today.
 
The institute will use Affy’s Genome-Wide Human SNP Array 6.0 over the next three years to screen the DNA of more than 12,000 people to identify associations that could help in the development of personalized treatments for CAD.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.